Physician profile
Christopher Ng
NPI 1124002845
$17,605.36
in general payments reported to CMS, 2019-2025
35 companies · $1,184 in 2025
The $1,184 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $189 · 2021: $1,051 · 2022: $12K · 2023: $1,494 · 2024: $791 · 2025: $1,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,921 · Consulting Fee: $450 · Education: $97.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,921.45 |
| Consulting Fee | $450.00 |
| Education | $97.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $11,416.34 | 2022-2023 | Monarch Platform |
| Abbvie INC. | $786.04 | 2019-2025 | |
| Astellas Pharma US INC | $637.01 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $463.58 | 2019-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $395.12 | 2020-2025 | Provenge |
| Urogen Pharma, INC. | $389.20 | 2023-2025 | Jelmyto |
| Pfizer INC. | $377.45 | 2019-2025 | |
| Myovant Sciences INC. | $327.67 | 2021-2022 | |
| Teleflex LLC | $242.85 | 2021-2023 | Urolift |
| Immunitybio, INC. | $224.33 | 2024-2025 | |
| Blue Earth Diagnostics | $212.58 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $196.22 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $185.59 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $184.60 | 2022-2025 | |
| Rochester Medical Corporation | $165.10 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $153.18 | 2023-2025 | Orgovyx |
| Coloplast Corp | $136.41 | 2021 | |
| Myriad Genetic Laboratories, INC. | $127.46 | 2021-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $122.34 | 2022-2025 | Lynparza, Welireg, Keytruda |
| Depuy Synthes Sales INC. | $119.62 | 2019 | |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Procept Biorobotics Corporation | $103.92 | 2019-2024 | Aquabeam System |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Boston Scientific Corporation | $86.59 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $75.62 | 2023 | Bard Urinary Drainage Bag |
| Amgen INC. | $54.99 | 2019 | |
| Progenics Pharmaceuticals, INC. | $41.45 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2022 | |
| Averitas Pharma INC. | $30.44 | 2023 | Qutenza |
| Ethicon US, LLC | $25.78 | 2021 | |
| Axonics, INC. | $22.39 | 2022 | |
| Urovant Sciences INC | $20.29 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $19.16 | 2021 | |
| Antares Pharma, INC. | $18.15 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.